Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of chromosomal microarray on clinical management: a retrospective analysis.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Sept 2014

Henderson Lindsay B, Applegate Carolyn D, Wohler Elizabeth, Sheridan Molly B, Hoover-Fong Julie, Batista Denise A S

Abstract excerpt

PURPOSE: Chromosomal microarray has been widely adopted as the first-tier clinical test for individuals with multiple congenital anomalies, developmental delay, intellectual disability, and autism spectrum disorders. Although chromosomal microarray has been extensively shown to provide a higher diagnostic yield than conventional cytogenetic methods, some health insurers refuse to provide coverage for this test,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Follow-Up Studies

Share to Genetic Testing

Share to Infant

Share to Oligonucleotide Array Sequence Analysis

Share to Referral and Consultation

Source

Identifiers

PMID: 24625444
DOI: 10.1038/gim.2014.18

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of chromosomal microarray on clinical management: a retrospective analysis.PMID 24625444Read ↗

Clinical Utility of Chromosomal Microarray AnalysisSemantic proximity Read ↗

Chromosomal microarray impacts clinical managementSemantic proximity Read ↗

Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisSemantic proximity Read ↗

Chromosomal microarray analyses from 5,778 patients with neurodevelopmental disorders and congenital anomalies in BrazilSemantic proximity Read ↗

Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesSemantic proximity Read ↗

Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital AnomaliesSemantic proximity Read ↗

Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic servicesSemantic proximity Read ↗

Reinterpretation of Chromosomal Microarrays with Detailed Medical History.Semantic proximity Read ↗

Chromosomal microarray analyses from 5778 patients with neurodevelopmental disorders and congenital anomalies in BrazilSemantic proximity Read ↗

Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in KoreaSemantic proximity Read ↗

Diagnostic Utility of Whole Genome Sequencing After Negative Karyotyping/Chromosomal Microarray in Infants Born With Multiple Congenital Anomalies.Semantic proximity Read ↗

Committee Opinion No. 581Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.